Skip to content

Generic Sweden Interim Report January–March 2022

May 18, 2022

Interim Report: January 1 – March 31, 2022 (compared with the same period last year)

  • Net sales increased by 19% to 31.9 MSEK (26.9 MSEK)
  • Operating profit (EBIT) improved by 10% and amounted to 6.3 MSEK (5.7 MSEK)
  • Earnings per share amounted to SEK 0.40 (SEK 0.37)
  • Cash flow from operating activities amounted to 3.1 MSEK (4.0 MSEK)

Note
Generic Sweden AB (publ) is required to disclose this information in accordance with the EU Market Abuse Regulation.
The information was submitted for publication by Susanne Lundin at 5:00 p.m. on May 18, 2022.

 

SHARE WITH US!